EDEN
PRAIRIE, Minn., July 24,
2024 /PRNewswire/ -- inFormed Consent, a pioneer in
digital informed consent and patient education technology,
announces its partnership with trifermed, a corporate strategy and
business development healthcare solutions
company, to introduce the new remote consent
capability to its current medical device markets and the new
inFormed Consent clinical data platform to clinical research
organizations and pharmaceutical companies.
trifermed, a Barcelona and
Cambridge, MA based company, is
recognized as a leader in connecting their clients with clinical
research organizations, pharmaceutical companies, and medical
device companies. trifermed will provide strategic and operational
support for the launch of the inFormed Consent platform in these
markets.
One of the biggest challenges clinical research projects face is
a lack of patient recruitment for their clinical studies.
Approximately 80% of clinical trials are delayed or closed due to
challenges related to patient recruitment and consent. These delays
can cost the sponsoring company as much as $600,000 per day when considering the impact of
delays on a new product commercial launch. Another challenge faced
is collecting clinical data from research sites due to the
additional burden placed on the research coordinators.
The inFormed Consent platform enables clinical research
companies to remotely present information related to a clinical
trial, ensures patient understanding, and asks the patient to
consent from the comfort of their own home. This patented
technology, which records the prospective patient as they watch a
video from a principal investigator explain the study, creates a
digital record that the patient was fully informed and agreed to
consent to the parameters of the study. Recent evidence and
experience indicate that the use of easy-to-understand content to
educate patients enable faster patient recruitment with a broader,
more diverse pool of study participants. Once patients are
enrolled, the platform's unique clinical data capabilities collect
the required information from participants with intelligent
questionnaires, specifically designed to significantly reduce the
data collection efforts.
We are thrilled to partner with trifermed and their talented
team to support our launch of our new remote capability and
expansion into these new markets. "In 2020, $245 billion was invested in clinical research
with 66% coming from industry. trifermed has for years established
strong relationships with many of these companies," said
Brad Hancock, Chief Executive
Officer, inFormed Consent. "The strength of these relationships was
underscored when trifermed presented the inFormed Consent platform
to potential partners at the recent BIO International Convention
annual meeting," he added.
"In partnering with inFormed Consent, we are excited to bring
our expertise in strategic healthcare solutions to a groundbreaking
technology that has the potential to revolutionize patient
recruitment and engagement in clinical trials. This collaboration
exemplifies our commitment to driving innovation and enhancing
patient experiences across the global health sector," said Prof.
Sergi X. Trilla, MD, MBA, Founder
and President of trifermed.
For more information about the inFormed
Consent platform and its remote patient consent technology
visit informedconsent.com.
About inFormed Consent
inFormed Consent is a
trailblazer in informed consent and patient education technology,
dedicated to empowering patients through accessible and informative
resources. By leveraging technology and collaboration, inFormed
Consent aims to revolutionize the patient experience with surgical
treatments, including spine procedures.
About trifermed
Founded in 2002, trifermed is a
leading corporate strategy and business development firm
specializing in the health sector, including pharmaceuticals,
biotechnology, medtech, and digital health. Headquartered in
Barcelona, Spain, with a
significant presence in Cambridge,
MA, USA, and Mexico City,
Mexico, trifermed has built a robust network and a
reputation for facilitating over 200 strategic partnerships across
more than 50 countries. The company excels in transforming
innovative ideas into market-ready solutions through a meticulous
approach to business strategy, incorporating deep market insights
and reducing uncertainty. trifermed's multidisciplinary team,
composed of experts in science, medicine, bioengineering, finance,
and commercial management, ensures comprehensive and tailored
solutions for clients ranging from startups to established entities
in the global health industry.
Media Contact:
Brad Hancock
Chief Executive Officer
inFormed Consent
(612) 244-0611
brad.hancock@informedconsent.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/informed-consent-announces-the-launch-of-remote-procedural-consent-and-the-informed-consent-platform-into-the-clinical-research-organization-and-pharmaceutical-markets-302204612.html
SOURCE inFormed Consent